Moderna COVID-19 boosters: FDA panel endorses lower-dose shots for seniors, high risk

A panel of independent advisers to the U.S. Food and Drug Administration unanimously voted to endorse lower-dose booster shots of Moderna’s COVID-19 vaccine for seniors and other high-risk groups.